Your browser doesn't support javascript.
loading
Correction to: Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial.
Mura, Mathilde; Rivoire, Emeraude; Dehina-Khenniche, Leila; Weiss-Gayet, Michèle; Chazaud, Bénédicte; Faes, Camille; Connes, Philippe; Long, Anne; Rytz, Chantal L; Mury, Pauline; Delrieu, Lidia; Gouraud, Etienne; Bordet, Marine; Della Schiava, Nellie; Lermusiaux, Patrick; Arsicot, Matthieu; Millon, Antoine; Pialoux, Vincent.
Afiliação
  • Mura M; Atherosclerosis, Thrombosis and Physical Activity, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Rivoire E; Atherosclerosis, Thrombosis and Physical Activity, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Dehina-Khenniche L; Vascular Medicine Department, Hopital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Weiss-Gayet M; Atherosclerosis, Thrombosis and Physical Activity, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Chazaud B; Vascular and Endovascular Surgery Department, Hopital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
  • Faes C; Stem Cell Environment and Skeletal Muscle Homeostasis, Institut NeuroMyoGene, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Connes P; Stem Cell Environment and Skeletal Muscle Homeostasis, Institut NeuroMyoGene, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Long A; Atherosclerosis, Thrombosis and Physical Activity, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Rytz CL; Vascular Biology and Red Blood Cell, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Mury P; Atherosclerosis, Thrombosis and Physical Activity, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Delrieu L; Vascular Medicine Department, Hopital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Gouraud E; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, 3230 Hospital Drive NW, Calgary, Alberta, Canada.
  • Bordet M; Center for Research, Montreal Heart Institute, Montreal, Quebec, Canada.
  • Della Schiava N; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, Paris, France.
  • Lermusiaux P; Atherosclerosis, Thrombosis and Physical Activity, LIBM EA7424, Université Lyon 1, University of Lyon, Lyon, France.
  • Arsicot M; Vascular and Endovascular Surgery Department, Hopital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
  • Millon A; Electrical Engineering and Ferroelectrical Laboratory, INSA Lyon, Lyon, France.
  • Pialoux V; Vascular and Endovascular Surgery Department, Hopital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
Trials ; 23(1): 230, 2022 Mar 22.
Article em En | MEDLINE | ID: mdl-35317830
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Evaluation_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Evaluation_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article